In the present study, we attempted to determine the potential involvement of CCR8+ Tregs in human HCC tissues and to examine the anticancer effect and the underlying molecular mechanisms of the CCR8 antagonistic antibody, IPG0521m, in murine liver cancer model. The gene discussed is CCR8; the disease is liver cancer.